Drug Delivery & Translational Research

  • Development of novel intranasal, pulmonary and ocular drug delivery system.
  • Delivery of therapeutic macromolecules including nucleic acids, genome editing systems (CRISPR/Cas9), monoclonal antibodies, proteins and peptides.
  • Engineering stimuli-response nanomaterials for targeted drug delivery.
  • Cocrystal research for improving drug delivery and manufacturability.
  • Development of consistent and stable nanoparticle-based drug delivery systems for superior therapeutic outcomes.
  • Novel strategies for enhancing drug solubility and stability.
  • Rational design of drug formulations and manufacturing processes by proper statistical software and mathematical modelling.
Principal Investigators